Fig. 1 | Scientific Reports

Fig. 1

From: Implementing electronic informed consent in rare disease genomics

Fig. 1

eConsent platform and consent process. Each Genomic Medicine Center (GMC) functions as a study site with its own portal entry. During the pilot phase, only GMC South (red arrow), GMC West (pink arrow), and GMC Karolinska (green arrow) were active. Invited potential participants received a letter with instructions for logging in using a digital ID, reviewing the Participant Information Sheet, and providing consent to participate. The signed consents were stored in a database accessible to both the GMCs and the National Genomic Data Platform (NGP). Created with BioRender.com.

Back to article page